APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: Results of case-control and family-based studies

Diabetes

Volumn 49, Issue 12, 2000, Pages 2190-2195

  Araki, Shin Ichi ^a,c   Moczulski, Dariusz K ^a,d   Hanna, Linda ^a   Scott, Laura J ^a   Warram, James H ^a   Krolewski, Andrzej S ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^d MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; DNA;

ADOLESCENT; ADULT; ALLELISM; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FAMILY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0033651349     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.12.2190     Document Type: Article

References (40)

1. Magnitude and determinants of coronary artery disease in juvenile onset, insulin dependent diabetes mellitus
2. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study
3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
4. Epidemiologic approach to the etiology of type 1 diabetes mellitus and its complications
5. Is diabetic nephropathy an inherited complication?
6. Familial factors determine the development of diabetic nephropathy in patients with IDDM
7. Genetic susceptibility to nephropathy in insulin-dependent diabetes: From epidemiology to molecular genetics
8. Association of apolipoprotein ε 2 allele with diabetic nephropathy in Caucasian subjects with IDDM
9. Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients
10. Increased frequency of apolipoprotein ε2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy
11. Apolipoprotein E genotypes and risk of diabetic nephropathy
12. Apolipoprotein E 4 reduces risk of diabetic nephropathy in patients with NIDDM
13. ApoE polymorphism and albuminuria in diabetes mellitus: A role for LDL in the development of nephropathy in NIDDM?
14. Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus
15. Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects
16. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
17. Structures and functions of multiligand lipoprotein receptors: Macrophage scavenger receptors and LDL receptor-related protein (LRP)
18. Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans: Apolipoproteins E3 and E2 greater than E4
19. Phenotype study of apolipoprotein E isoforms in hyperlipoproteinaemic patients
20. Novel mechanism for defective receptor binding of apolipoprotein E2 in type Ill hyperlipoproteinemia
21. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
22. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: The Framingham offspring study
23. Lipoprotein glomerulopathy: Report of a normolipidemic case and review of the literature
24. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM)
25. Effect of duration of type 1 diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio
26. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene
27. A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the ε 4 allele
28. Human apoCI HpaI restriction site polymorphism revealed by the polymerase chain reaction
29. Single-day apolipoprotein E genotyping
30. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease
31. The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes
32. Faster multipoint linkage analysis using Fourier transforms
33. Lack of contribution of lipid gene polymorphisms to IDDM nephropathy: The GENE-DIAB Study
34. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve
35. Immunohistological localization of apolipoproteins in the glomeruli in renal disease: Specifically apoB and apoE
36. Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases
37. Lipoprotein giomerulopathy: A new cause of nephrotic syndrome after renal transplantation
38. Apolipoprotein E2/E 5 variants in lipoprotein glomerulopathy recurred in transplanted kidney
39. Genetic associations with human longevity at the APOE and ACE loci